Dan McKay
Keine laufenden Positionen mehr
Profil
Dan McKay is Vice President-Business Development and Intellectual Property of Nuvo Research, Inc., which he joined in 2005.
Prior to joining Nuvo, he worked for Intellectual Property, Patents and Life Cycle Management of Janssen-Ortho, Inc. Previously, Mr. McKay worked for Bereskin & Parr and Gowling, Lafleur & Henderson.
He received a Bachelor of Science degree in Molecular Biology from McGill University and is a graduate of the Osgoode Hall Law School.
Ehemalige bekannte Positionen von Dan McKay
| Unternehmen | Position | Ende |
|---|---|---|
| NUVO PHARMACEUTICALS INC. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Nuvo Pharmaceuticals, Inc.
 Nuvo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nuvo Pharmaceuticals, Inc. is a pharmaceutical company, which is engaged in developing innovative therapeutic pharmaceutical products. It operates through the following segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. The Commercial Business segment includes Blexten, Cambia, the canadian business for Resultz and Suvexx, and mature assets. The Production and Service Business segment supplies Pennsaid to Horizon for the U.S. market and is engaged in ongoing partnering efforts for Pennsaid. The Licensing and Royalty Business segment engages in the selling of Vimovo. The company was founded on August 22, 1983 and is headquartered in Mississauga, Canada. | Health Technology |